NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-046-2019-0-PCT-01 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging PCT PCT PCT/US2019/018153 Expired
NLM E-124-2017-1-US-03 METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS US National Stage 16/326,132 Pending
NEI E-134-2016-0-US-07 SELECTIVE ESTROGEN-RECEPTOR MODULATORS (SERMS) CONFER PROTECTION AGAINST
PHOTORECEPTOR DEGENERATION 		US National Stage 16/325,678 11040019 Issued PDF
NCI E-036-2018-0-PCT-02 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS PCT PCT PCT/US2019/018057 Expired
NCI E-036-2018-0-EP-05 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS EP National Stage 19754834.0 Abandoned
NCI E-036-2018-0-CA-07 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS CA National Stage 3091423 Abandoned
NCI E-036-2018-0-JP-06 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS JP National Stage 2020-543808 Abandoned
CC E-001-2019-0-US-01 Handgrip Relaxometer Devices US 62/805,750 Abandoned
NCI E-190-2014-0-EP-14 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		EP DIV 19156541.5 Issued
NCI E-190-2014-0-GB-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		GB EP 19156541.5 Issued
NCI E-190-2014-0-IT-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		IT EP 19156541.5 Issued
NCI E-190-2014-0-FR-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		FR EP 19156541.5 Issued
NCI E-190-2014-0-DE-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		DE EP 19156541.5 Issued
NCI E-190-2014-0-ES-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		ES EP 19156541.5 Issued
NIDDK E-028-2018-1-PCT-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS PCT PCT COMB PCT/US19/17422 Expired
NCI E-053-2019-0-US-01 GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCs) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU US 62/803,468 Abandoned
NCI E-041-2018-0-EP-03 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER EP National Stage 19707221.8 Issued
NCI E-080-2018-0-EP-06 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY EP National Stage 19707555.9 Issued
NCI E-080-2018-0-IN-07 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY IN National Stage 202037038092 Issued
NCI E-080-2018-0-JP-08 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY JP National Stage 2020-542544 Issued
NICHD E-173-2016-0-US-07 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS US National Stage 16/324,413 11415652 Issued PDF
NCATS E-229-2016-0-US-04 PEPTIDE INHIBITORS OF PHOSPHOGLYCERATE MUTASE AND METHODS OF USE US National Stage 16/324,424 10808010 Issued PDF
NIAID E-099-2016-1-US-04 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US DIV 16/271,577 10668114 Abandoned PDF
NIAID E-099-2016-1-US-03 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US DIV 16/271,552 10500238 Abandoned PDF
NCI E-080-2018-0-PCT-02 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY PCT PCT PCT/US2019/017354 Expired
NCI E-041-2018-0-PCT-02 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER PCT PCT PCT/US2019/017239 Expired
NCI E-080-2018-0-CN-05 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY CN National Stage 201980012620.8 Pending
NCI E-080-2018-0-CA-04 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY CA National Stage 3089396 Pending
NCI E-080-2018-0-AU-03 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY AU National Stage 2019216781 Pending
NICHD E-014-2019-0-US-01 COMPOSITE GELS AND METHODS OF USE THEREOF US 62/802,885 Abandoned
NIAID E-032-2019-0-US-01 Nanoparticle-based Influenza Virus Vaccines and Uses Thereof US 62/803,218 Abandoned
NICHD E-173-2016-0-JP-06 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS JP National Stage 2019-506625 Issued
NCI E-068-2018-0-PCT-02 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 PCT PCT PCT/US2019/016975 Expired
NCI E-245-2016-0-US-05 NEAR-IR LIGHT-CLEAVABLE CONJUGATES AND CONJUGATE PRECURSORS US National Stage 16/323,747 10561729 Issued PDF
NIDA E-023-2018-0-PCT-02 DREADD ACTUATORS PCT PCT PCT/US2019/016892 Expired
NICHD E-173-2016-0-EP-05 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS EP National Stage 17755012.6 Issued
NICHD E-173-2016-0-GB-01 MULTI-DIMENSIONAL SPECTROSCOPIC NMR AND MRI USING MARGINAL DISTRIBUTIONS GB EP 17755012.6 Issued
NCI E-106-2018-0-US-02 Use Of Cell Permeable Inhibitors Of Tyrosyl-DNA Phosphodiesterase 2 (TDP2) To Potentiate TOP2 Inhibitors As Anticancer Agents US ORD 16/267,274 10617706 Issued PDF
NCI E-211-2016-0-US-05 MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 (GPC2) AND USE THEREOF US National Stage 16/322,712 11066479 Issued PDF
NINDS E-252-2016-1-EP-02 Diagnosing COL6-Related Disorders And Methods For Treating Same EP National Stage 17824810.0 Pending
NIAID E-089-2019-0-US-01 SIRPalpha Expression On T Cells Is A Biomarker For Functional T Cells During Exhaustion US 62/800,333 Abandoned
NCI E-767-2013-0-EP-11 Certain Improved Human Bispecific EGFRvIII Antibody Engaging Molecules EP DIV 19154412.1 Pending
CC E-103-2018-0-US-01 Transfusion-Transmitted Infections RNA Viruses Chi - TTI RNA-Chip US 62/799,482 Abandoned
NCI E-215-2017-0-CA-04 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES CA National Stage 3088410 Issued
NCI E-215-2017-0-JP-06 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES JP National Stage 2020-542077 Issued
NCI E-215-2017-0-GB-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES GB EP 19705051.1 Issued
NCI E-215-2017-0-CH-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES CH EP 19705051.1 Issued
NCI E-215-2017-0-EP-05 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES EP National Stage 19705051.1 Issued
NCI E-215-2017-0-FR-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES FR EP 19705051.1 Issued
NCI E-215-2017-0-DE-01 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES DE EP 19705051.1 Issued